Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients

被引:37
作者
Liu, Chenglei [1 ]
Xi, Yan [1 ]
Li, Mei [1 ]
Jiao, Qiong [2 ]
Zhang, Huizhen [2 ]
Yang, Qingcheng [3 ]
Yao, Weiwu [1 ]
机构
[1] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Radiol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Pathol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthoped, Shanghai, Peoples R China
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
CHEMOTHERAPY; EXPERIENCE; MRI;
D O I
10.1371/journal.pone.0173665
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor survival. There are many confusing issues concerning the imaging feature that can facilitate early diagnosis and the factors that might be related to outcomes. Methods Twenty-three patients with dedifferentiated chondrosarcoma confirmed by pathology were retrospectively reviewed from 2008 to 2015. The patients' clinical information, images from radiographs (n = 17), CT (n = 19), and MRI (n = 17), histological features, treatment and prognosis were analyzed. Results There were 12 males and 11 females, and the mean age was 50.39 years old. Fourteen cases affected the axial bone (pelvis, spine), and 9 cases involved the appendicular bone. Seven (41.17%), 9 (47.36), and 12 (66.66%) lesions showed a biphasic nature on radiograph, CT and MRI, respectively. Of the lesions, 17.39% (4/23) were accompanied by pathological fractures. Histologically, the cartilage component was considered histological Grade1 in 12 patients and Grade 2 in 11 patients. The dedifferentiated component showed features of osteosarcoma in 8 cases, malignant fibrous histiocytoma in3 cases, myofibroblastic sarcoma in 1 case and spindle cell sarcoma in 11cases. Twenty-two cases were treated with surgical resection, and 17 cases achieved adequate (wide or radical) surgical margin. In 8 cases, surgery was combined with adjuvant chemotherapy. The overall median survival time was nine months; 17.4% of patients survived to five years. Conclusion Axial bone location, lung metastasis at diagnosis, inadequate surgical margin, incorrect diagnosis before surgery and pathological fractures was related to poorer outcome. Pre- or postoperative chemotherapy had no definitively effect on improved survival.
引用
收藏
页数:15
相关论文
共 30 条
  • [1] Bergh P, 2001, CANCER-AM CANCER SOC, V91, P1201, DOI 10.1002/1097-0142(20010401)91:7<1201::AID-CNCR1120>3.0.CO
  • [2] 2-W
  • [3] Dedifferentiated chondrosarcoma - a fatal disease
    Bruns, J
    Fiedler, W
    Werner, M
    Delling, G
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (06) : 333 - 339
  • [4] TIME AND DOSE DEPENDENCY OF BONE-SARCOMAS IN PATIENTS INJECTED WITH RADIUM-224
    CHMELEVSKY, D
    KELLERER, AM
    LAND, CE
    MAYS, CW
    SPIESS, H
    [J]. RADIATION AND ENVIRONMENTAL BIOPHYSICS, 1988, 27 (02) : 103 - 114
  • [5] DAHLIN DC, 1971, CANCER, V28, P461, DOI 10.1002/1097-0142(197108)28:2<461::AID-CNCR2820280227>3.0.CO
  • [6] 2-U
  • [7] DALY PJ, 1989, ORTHOPEDICS, V12, P763
  • [8] DEDIFFERENTIATED CHONDROSARCOMA - RADIOGRAPHIC FEATURES
    DELANGE, EE
    POPE, TL
    FECHNER, RE
    [J]. RADIOLOGY, 1986, 161 (02) : 489 - 492
  • [9] Dedifferentiated chondrosarcoma: The role of chemotherapy with updated outcomes
    Dickey, ID
    Rose, PS
    Fuchs, B
    Wold, LE
    Okuno, SH
    Sim, FH
    Scully, SP
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2004, 86A (11) : 2412 - 2418
  • [10] MR imaging of dedifferentiated chondrosarcoma
    Eustace, S
    Baker, N
    Lan, H
    Wadhwani, A
    Dorfman, D
    [J]. CLINICAL IMAGING, 1997, 21 (03) : 170 - 174